Mera Pharmaceuticals
MRPI · OTC
$0.00−$0.0001 (−100.00%)TodayMarket closed ·
No price history for this range.
Key indicators
MRPI profitability and balance sheet ratios
EPS -$0.0002 in Oct 2011, against -$0.0007 a year earlier.
| Period | EPS |
|---|---|
| Jan 2010 | -$0.00 |
| Apr 2010 | -$0.0001 |
| Jul 2010 | -$0.0001 |
| Oct 2010 | -$0.0007 |
| Jan 2011 | -$0.0001 |
| Apr 2011 | -$0.0001 |
| Jul 2011 | -$0.00 |
| Oct 2011 | -$0.0002 |
Income statement
No financial statements are reported for Mera Pharmaceuticals.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Apr 2011 | Jul 2011 | Oct 2011 |
|---|---|---|---|
| Total assets | $0.0M | $0.1M | $0.1M |
| Total liabilities | $0.8M | $0.8M | $0.9M |
| Shareholder equity | −$0.7M | −$0.8M | −$0.9M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $0.1M | $0.1M | $0.1M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.